rs146459055

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_004738.5(VAPB):​c.390T>G​(p.Asp130Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000723 in 1,612,812 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00067 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00073 ( 3 hom. )

Consequence

VAPB
NM_004738.5 missense

Scores

19

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 1.70

Publications

18 publications found
Variant links:
Genes affected
VAPB (HGNC:12649): (VAMP associated protein B and C) The protein encoded by this gene is a type IV membrane protein found in plasma and intracellular vesicle membranes. The encoded protein is found as a homodimer and as a heterodimer with VAPA. This protein also can interact with VAMP1 and VAMP2 and may be involved in vesicle trafficking. [provided by RefSeq, Jul 2008]
VAPB Gene-Disease associations (from GenCC):
  • amyotrophic lateral sclerosis type 8
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • adult-onset proximal spinal muscular atrophy, autosomal dominant
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004738.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00932765).
BP6
Variant 20-58439019-T-G is Benign according to our data. Variant chr20-58439019-T-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259538.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 102 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004738.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VAPB
NM_004738.5
MANE Select
c.390T>Gp.Asp130Glu
missense
Exon 4 of 6NP_004729.1O95292-1
VAPB
NM_001195677.2
c.212-5058T>G
intron
N/ANP_001182606.1O95292-2
VAPB
NR_036633.2
n.443-1888T>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
VAPB
ENST00000475243.6
TSL:1 MANE Select
c.390T>Gp.Asp130Glu
missense
Exon 4 of 6ENSP00000417175.1O95292-1
VAPB
ENST00000395802.7
TSL:1
c.212-5058T>G
intron
N/AENSP00000379147.3O95292-2
VAPB
ENST00000903510.1
c.450T>Gp.Asp150Glu
missense
Exon 5 of 7ENSP00000573569.1

Frequencies

GnomAD3 genomes
AF:
0.000670
AC:
102
AN:
152234
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000720
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00130
AC:
326
AN:
250816
AF XY:
0.00118
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00278
Gnomad ASJ exome
AF:
0.00526
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000420
Gnomad NFE exome
AF:
0.00122
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000729
AC:
1064
AN:
1460460
Hom.:
3
Cov.:
30
AF XY:
0.000764
AC XY:
555
AN XY:
726644
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33460
American (AMR)
AF:
0.00253
AC:
113
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00540
AC:
141
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39644
South Asian (SAS)
AF:
0.000731
AC:
63
AN:
86230
European-Finnish (FIN)
AF:
0.000301
AC:
16
AN:
53138
Middle Eastern (MID)
AF:
0.00416
AC:
24
AN:
5766
European-Non Finnish (NFE)
AF:
0.000579
AC:
643
AN:
1111028
Other (OTH)
AF:
0.00104
AC:
63
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
50
99
149
198
248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000670
AC:
102
AN:
152352
Hom.:
0
Cov.:
32
AF XY:
0.000631
AC XY:
47
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41572
American (AMR)
AF:
0.00118
AC:
18
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4834
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000720
AC:
49
AN:
68038
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00104
Hom.:
0
Bravo
AF:
0.000827
EpiCase
AF:
0.00142
EpiControl
AF:
0.00172

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
2
Adult-onset proximal spinal muscular atrophy, autosomal dominant (2)
-
-
2
Amyotrophic lateral sclerosis type 8 (2)
-
-
1
Amyotrophic lateral sclerosis type 8;C1854058:Adult-onset proximal spinal muscular atrophy, autosomal dominant (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
21
DANN
Benign
0.96
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.39
Eigen_PC
Benign
-0.16
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.85
T
M_CAP
Benign
0.0077
T
MetaRNN
Benign
0.0093
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.85
L
PhyloP100
1.7
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.097
Sift
Benign
0.27
T
Sift4G
Benign
0.60
T
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.11
gMVP
0.056
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs146459055;
hg19: chr20-57014075;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.